Bio-Thera Solutions, Ltd. (SHA:688177)
China · Delayed Price · Currency is CNY 19.14
-0.04 (-0.21%)
At close: Jun 1, 2026
Bio-Thera Solutions Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -331.94 | -510.3 | -394.53 | -480.4 | 81.94 |
Depreciation & Amortization | 104.31 | 87.86 | 85.24 | 83.84 | 72.94 |
Other Amortization | 0.94 | 2.18 | 0.11 | - | - |
Loss (Gain) From Sale of Assets | 1.72 | 0.01 | -0.03 | -0 | - |
Asset Writedown & Restructuring Costs | 0.47 | -2.95 | -6.92 | 0.07 | 0.02 |
Loss (Gain) From Sale of Investments | -0.83 | -1.23 | -3.87 | -25.03 | -27.6 |
Provision & Write-off of Bad Debts | - | 0.23 | 0.19 | -0.71 | 0.9 |
Other Operating Activities | 20.24 | 20.86 | 11.78 | 0.63 | 0.69 |
Change in Accounts Receivable | -166.03 | 44.85 | -99.3 | 27.1 | 21.88 |
Change in Inventory | -59.42 | -21.87 | -69.33 | -71.8 | -44.47 |
Change in Accounts Payable | 348.43 | 299.37 | 41.14 | 53.48 | 129.99 |
Change in Other Net Operating Assets | - | 25.35 | -25.35 | - | - |
Operating Cash Flow | -82.11 | -55.65 | -460.87 | -412.82 | 236.27 |
Capital Expenditures | -121.74 | -126.85 | -262.14 | -258.82 | -77.89 |
Sale of Property, Plant & Equipment | 0.18 | 0 | 0 | 0.03 | 0 |
Investment in Securities | 90 | 240 | 288 | -28 | 340 |
Other Investing Activities | 22.87 | 5.49 | 11.71 | 40.99 | 39.65 |
Investing Cash Flow | -8.69 | 118.64 | 37.57 | -245.8 | 301.76 |
Long-Term Debt Issued | 360.27 | 378.93 | 441.85 | 3 | 30 |
Total Debt Issued | 360.27 | 378.93 | 441.85 | 3 | 30 |
Long-Term Debt Repaid | -298.53 | -277.73 | -34.97 | -32.99 | -2.91 |
Total Debt Repaid | -298.53 | -277.73 | -34.97 | -32.99 | -2.91 |
Net Debt Issued (Repaid) | 61.74 | 101.2 | 406.88 | -29.99 | 27.09 |
Common Dividends Paid | -20.39 | -20.6 | -9.32 | -0.16 | -0.55 |
Other Financing Activities | -0.06 | 6.69 | -2.4 | - | - |
Financing Cash Flow | 41.29 | 87.28 | 395.16 | -30.15 | 26.54 |
Foreign Exchange Rate Adjustments | -0.58 | 0.61 | 0.57 | 0.77 | -0.8 |
Net Cash Flow | -50.1 | 150.88 | -27.58 | -688 | 563.77 |
Free Cash Flow | -203.86 | -182.5 | -723.01 | -671.64 | 158.38 |
Free Cash Flow Margin | -21.80% | -24.56% | -102.58% | -147.57% | 18.93% |
Free Cash Flow Per Share | -0.49 | -0.44 | -1.74 | -1.62 | 0.39 |
Cash Income Tax Paid | 18.52 | 19.94 | -23.92 | -34.41 | -24.37 |
Levered Free Cash Flow | -246.98 | -108.15 | -591.18 | -510.64 | 34.74 |
Unlevered Free Cash Flow | -246.98 | -95.31 | -584.69 | -510.6 | 35.23 |
Change in Working Capital | 122.98 | 347.69 | -152.84 | 8.78 | 107.4 |